Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Motiva USA, LLC

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Motiva USA, LLC

Regulatory records
4
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 4 FDA records to the applicant name Motiva USA, LLC. It includes 1 original PMA approval. 2 entries are PMA supplements. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Sep 26, 2024 to Oct 2, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code FTR appears in 4 of the 4 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P230005, with 4 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 3 linked filings have a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 2543 Mesa School Ln., Santa Barbara, CA, 93109. Recorded on P230005/S002, decision dated Oct 2, 2026.

Changes described in PMA records

P230005/S002: Motiva SmoothSilk Round Ergonomix Silicone Gel-Filled Breast Implants, Motiva SmoothSilk Round Silicone Gel-Filled Breas

FDA approved supplement S002 to PMA P230005 for Motiva SmoothSilk Round Ergonomix and Motiva SmoothSilk Round silicone gel-filled breast implants. The decision, dated October 2, 2026, is an approval for a product line extension to smaller size devices. The supplement type is a Normal 180 Day Track, and the stated reason is a change in design, components, specifications, or material.

The device is classified as a noninflatable, internal, silicone gel-filled breast prosthesis under product code FTR, in the general and plastic surgery specialty. The applicant is Motiva USA, LLC. The source statement does not include specific smaller sizes, dimensional specifications, or clinical data. A supplement approval does not represent a new approval of the entire PMA system.

FDA approval-order wording

Approval for the product line extension to smaller size devices

Oct 2, 2026 · Normal 180 Day Track

P230005/S005: Motiva SmoothSilk Round and Round Ergonomix Silicone Gel-Filled Breast Implants

The FDA record for P230005/S005 is a 30-day notice review track supplement classified as a process change covering manufacturer, sterilizer, packager or supplier. For Motiva SmoothSilk Round and Round Ergonomix silicone gel-filled breast implants, the stated purpose is adding an additional supplier for the shell patch and patch filler components. The decision field is listed as APPR, dated 2026-09-25, under product code FTR, specialty general and plastic surgery, applicant Motiva USA, LLC.

Because the identifier ties S005 to PMA P230005, this is a supplement to that original approval rather than an approval of the whole implant system. The record does not specify which supplier was added, the composition of the shell patch or patch filler, or any test data. The reported purpose of the submission is a stated change, not independent evidence of safety or clinical effectiveness, and no clinical conclusions follow.

Specific details absent from the supplied fields include supplier identity and any supporting manufacturing or performance information.

FDA approval-order wording

adding an additional supplier for the shell patch and patch filler components

Sep 25, 2026 · 135 Review Track For 30-Day Notice

P230005: Motiva SmoothSilk Round Ergonomix Silicone Gel-Filled Breast Implants, Motiva SmoothSilk Round Silicone Gel-Filled Breas

FDA approved PMA P230005 for Motiva SmoothSilk Round and SmoothSilk Round Ergonomix silicone gel-filled breast implants. The approval statement lists the indication as breast augmentation for women at least 22 years old, including primary augmentation to increase breast size and revision surgery to correct or improve the result of an original primary augmentation.

The device category is a noninflatable internal silicone gel-filled breast prosthesis under product code FTR. The applicant is Motiva USA, LLC, and the decision date is September 26, 2024. The source statement does not include safety or effectiveness findings, clinical trial data, or a supplement relationship to any earlier PMA.

FDA approval-order wording

The Motiva SmoothSilk Round and SmoothSilk Round Ergonomix breast implants are indicated for breast augmentation for women of at least 22 years old. Breast augmentation includes primary breast augmentation to increase the breast size, as well as revision surgery to correct or improve the result of an original primary breast augmentation surgery (i.e., revision-augmentation).

Sep 26, 2024

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.